Evidence map›Paper›PMID 35540130›Full record

ArticleRSC advances2018

Antimicrobial synergy of cationic grafted poly(

Jordan McBrearty, David Barker, Mona Damavandi, Joels Wilson-Nieuwenhuis, Lisa I Pilkington, Nina Dempsey-Hibbert, Anthony J Slate, Kathryn A Whitehead

Abstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jordan McBreartyMicrobiology at Interfaces Group, Faculty of Science and Engineering, Manchester Metropolitan University Manchester M1 5GD UK K.A.Whitehead@mmu.ac.uk +44(0) 161 247 1157.
David BarkerSchool of Chemical Sciences, University of Auckland Auckland 1010 New Zealand.ORCID https://orcid.org/0000-0002-3425-6552
Mona DamavandiSchool of Chemical Sciences, University of Auckland Auckland 1010 New Zealand.
Joels Wilson-NieuwenhuisMicrobiology at Interfaces Group, Faculty of Science and Engineering, Manchester Metropolitan University Manchester M1 5GD UK K.A.Whitehead@mmu.ac.uk +44(0) 161 247 1157.
Lisa I PilkingtonSchool of Chemical Sciences, University of Auckland Auckland 1010 New Zealand.
Nina Dempsey-HibbertMicrobiology at Interfaces Group, Faculty of Science and Engineering, Manchester Metropolitan University Manchester M1 5GD UK K.A.Whitehead@mmu.ac.uk +44(0) 161 247 1157.
Anthony J SlateMicrobiology at Interfaces Group, Faculty of Science and Engineering, Manchester Metropolitan University Manchester M1 5GD UK K.A.Whitehead@mmu.ac.uk +44(0) 161 247 1157.ORCID https://orcid.org/0000-0002-7062-6901
Kathryn A WhiteheadMicrobiology at Interfaces Group, Faculty of Science and Engineering, Manchester Metropolitan University Manchester M1 5GD UK K.A.Whitehead@mmu.ac.uk +44(0) 161 247 1157.ORCID https://orcid.org/0000-0001-6001-6686

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise in multidrug resistant bacteria is an area of growing concern and it is essential to identify new biocidal agents. Cationic grafted compounds were investigated for their antimicrobial properties using minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) tests. Synergy testing was carried out using the compounds in the presence of ultraviolet (UV). Fractional inhibitory concentration (FIC) and fractional bactericidal concentration (FBC) tests were carried out using the cationic molecules in conjunction with metal ion solutions of gold, silver, palladium, platinum, rhodium, titanium, tin, vanadium and molybdenum. Individually, the cationic compounds containing quaternary amines, polyphenylene vinylene (PPV) with long polyacrylate grafts (PPV-

Identifiers

PMID35540130
PMCPMC9081575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.